January 18, 2022
Identifying best candidates with avascular necrosis for regenerative alternative to hip replacement
A regenerative alternative to total hip replacement delayed the need for artificial implants by at least seven years for 35% of patients who had surgery to treat avascular necrosis. That condition occurs when blood flow to the hip joint known as the femoral head is constricted, causing bone cells to die. This Mayo Clinic research, […]
Tags: biotherapeutics, Center for Regenerative Medicine, hip decompression surgery, hip replacement, orthopedics, Rafael Sierra, regenerative medicine research
October 20, 2021
Overcoming regulatory challenges to licensing new biotherapeutics
Mayo Clinic’s Symposium on Regenerative Medicine and Surgery will explore the challenges and opportunities of bringing next-generation biotherapeutics to patients. Julie Allickson, Ph.D., the Michael S. and Mary Sue Shannon Director of Mayo Clinic’s Center for Regenerative Medicine, will deliver a keynote presentation addressing regulatory hurdles standing between the billions of dollars invested in regenerative […]
Tags: Atta Behfar, biotherapeutics, Center for Regenerative Medicine, Julie Allickson, Mayo Clinic Symposium on Regenerative Medicine & Surgery, Richard Hayden, William Faubion Jr.
September 27, 2021
A robotic GPS for targeting, delivering regenerative biotherapies
A remote-controlled bronchoscope that acts like a GPS system hunts down hard to find lung masses and accurately biopsies them, according to a Mayo Clinic collaborative study. This multisite research, which is published in Annals of Thoracic Surgery, lays the foundation for precisely finding early stage cancer and targeting it with regenerative biotherapeutics needed to […]
Tags: biotherapeutics, Center for Regenerative Medicine, early stage lung cancer, Janani Reisenauer, Julie Allickson, robotic bronchoscope